Live Breaking News & Updates on Ritter Pharmaceuticals Inc
Stay updated with breaking news from Ritter pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among the many functions that automated liquid handling systems are equipped to accomplish in laboratories is the automatic collection, separation, and ....
MedCity News Docbot CEO highlights how AI can be applied to gastrointestinal image analysis Docbot CEO Andrew Ritter talked about how the predictive analytics business seeks to shake up how clinicians diagnose gastrointestinal disease by changing the way medical images are analyzed. Shares0 In an interview, Docbot CEO Andrew Ritter talked about how the predictive analytics business seeks to shake up how clinicians diagnose gastrointestinal disease by changing the way medical images are analyzed. Why did you start this company? The original co-founder, Andrew Ninh started the company because he experienced a collapsed lung which caused him to miss his high school graduation. During this time, he saw that healthcare desperately needed IT systems that are safer for patients, physicians and nurses. He later met Dr. William Karnes, a leading gastroenterologist at UC Irvine, who explained the current standard of care for colonoscopies. Together, they started Do ....
EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma Mon, 1st Mar 2021 16:41 (Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Moves Chief Investment Officer Richard Pye to chief financial officer and executive director, while interim CFO Michael Norris moves to non-executive director, both from last Friday. Norris has been interim CFO since March last year. Additionally, Geoff Race joins the board as non-executive director. Race is co-founder and CFO of Nasdaq-listed biopharmaceutical company Minerva Neurosciences Inc. ....